Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 7:00 pm Purchase |
2025-03-06 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 8,511,824 19.990% |
570,134 (+7.18%) |
Filing History |
| 2025-02-27 6:43 pm Purchase |
2025-02-10 | 13G | Oruka Therapeutics, Inc. ORKA |
Venrock Healthcare Capital Partners III L.P. | 4,148,428 11.100% |
606,487 (+17.12%) |
Filing History |
| 2024-11-21 6:30 pm Purchase |
2024-11-19 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 7,941,690 19.990% |
17 (+0.00%) |
Filing History |
| 2024-11-14 7:38 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Avidity Partners Management LP | 790,926 2.300% |
790,926 (New Position) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Venrock Healthcare Capital Partners III L.P. | 3,541,941 9.990% |
3,541,941 (New Position) |
Filing History |
| 2024-11-14 12:04 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Allostery Investments LP | 43,557 0.300% |
43,557 (New Position) |
Filing History |
| 2024-11-14 09:56 am Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
JANUS HENDERSON GROUP PLC JHG |
236,116 0.700% |
236,116 (New Position) |
Filing History |
| 2024-10-22 4:15 pm Purchase |
2024-10-22 | 13D | Oruka Therapeutics, Inc. ORKA |
Adage Capital Management L.P. | 175,000 0.500% |
175,000 (New Position) |
Filing History |
| 2024-10-07 11:37 am Purchase |
2024-10-04 | 13G | Oruka Therapeutics, Inc. ORKA |
FMR CORP | 5,512,300 15.345% |
5,512,300 (New Position) |
Filing History |
| 2024-09-13 4:57 pm Purchase |
2024-09-11 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 7,941,673 19.990% |
1,330,418 (+20.12%) |
Filing History |
| 2024-09-06 5:08 pm Purchase |
2024-08-29 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 6,611,255 19.990% |
6,611,255 (New Position) |
Filing History |
| 2024-07-05 5:20 pm Purchase |
2024-07-02 | 13G | ARCA biopharma, Inc. ABIO |
JANUS HENDERSON GROUP PLC JHG |
123,545 10.200% |
33,536 (+37.26%) |
Filing History |
| 2024-04-29 7:28 pm Purchase |
2024-04-17 | 13G | ARCA biopharma, Inc. ABIO |
Venrock Healthcare Capital Partners III L.P. | 62,889 5.200% |
62,889 (New Position) |
Filing History |
| 2024-04-15 5:29 pm Purchase |
2024-04-03 | 13G | ARCA biopharma, Inc. ABIO |
Allostery Investments LP | 88,751 7.300% |
88,751 (New Position) |
Filing History |
| 2024-04-11 09:51 am Purchase |
2024-04-03 | 13G | ARCA biopharma, Inc. ABIO |
JANUS HENDERSON GROUP PLC JHG |
90,009 7.400% |
90,009 (New Position) |
Filing History |
| 2024-04-09 8:57 pm Purchase |
2024-04-03 | 13G | ARCA biopharma, Inc. ABIO |
Avidity Partners Management LP | 83,333 6.900% |
83,333 (New Position) |
Filing History |
| 2024-04-05 7:38 pm Purchase |
2023-12-31 | 13G | ARCA biopharma, Inc. ABIO |
Western Standard, LLC | 117,512 9.800% |
38,826 (+49.34%) |
Filing History |
| 2024-04-05 4:05 pm Purchase |
2024-04-03 | 13D | ARCA biopharma, Inc. ABIO |
Adage Capital Management L.P. | 100,000 8.280% |
100,000 (New Position) |
Filing History |
| 2024-02-07 1:08 pm Sale |
2023-12-31 | 13G | ARCA biopharma, Inc. ABIO |
BML Investment Partners, L.P. | 58,911 4.900% |
-12,611 (-17.63%) |
Filing History |
| 2023-09-11 4:01 pm Purchase |
2023-08-30 | 13G | ARCA biopharma, Inc. ABIO |
Western Standard, LLC | 78,686 6.600% |
78,686 (New Position) |
Filing History |